Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Octagam is a solvent/detergent-treated human normal immunoglobulin (IGIV) solution for
intravenous administration. Octagam 5% is currently registered in about 80 countries. This
study evaluated the efficacy and safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura
(ITP) in adults. As Octagam 10% is essentially similar to Octagam 5%, it is expected that
Octagam 10% is as efficacious and safe (in respect to viral safety) as Octagam 5%.